Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Head And Neck Cancer (HNC) Market Through 2034?
The market for head and neck cancer (hnc) has seen robust growth in the past few years. Starting from a value of $2 billion in 2024, it is projected to expand to $2.16 billion in 2025, an increase represented by a compound annual growth rate (CAGR) of 8.2%. Several factors have influenced this substantial growth in the historical period. Among these are a rise in HPV-related cancers, escalating rates of smoking and alcohol consumption, amplified investments in cancer research, elevated awareness and early detection, coupled with a growing elderly population.
Anticipated vigorous expansion is on the horizon for the head and neck cancer (hnc) market in the upcoming years. Projections estimate that the growth will hit $2.91 billion in 2029, with a compound annual growth rate (CAGR) of 7.7%. The significant growth within the forecast period can be tied to a developed healthcare framework, an increase in patient numbers, the growing older population, increased health care spending, and the widespread prevalence of tobacco and alcohol usage. On the horizon, key trends to watch include advancements in immunotherapy, targeted treatments, technological incorporation, the integration of artificial intelligence (AI), and precision medicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20825&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Head And Neck Cancer (HNC) Market?
The surge in cigarette smoking incidents is expected to spur the expansion of the head and neck cancer (HNC) market in the future. Inhaling and exhaling smoke from burning tobacco encased in cigarettes, an activity fraught with health hazards and addiction, is commonly referred to as cigarette smoking. Factors like stress, social impact, aggressive advertising, and the easy availability of tobacco products often contribute to the rise in cigarette smoking. Medications for head and neck cancer serve to counteract the detrimental effects of cigarette smoking by tackling molecular changes brought about by smoking and addressing cancers associated with tobacco consumption. They further underscore the necessity to lessen exposure to carcinogens associated with smoking for improved treatment results. For example, a survey by the European Respiratory Society (ERS), a non-profit organization based in Switzerland, studying smoking patterns in young people in October 2024 reported a considerable escalation in smoking rates, from 22.5% in 2022 to 40.1% in 2024. Thus, the climbing incidence of cigarette smoking is fueling the growth of the head and neck cancer (HNC) market.
Which Key Market Segments Comprise the Head And Neck Cancer (HNC) Market and Drive Its Revenue Growth?
The head and neck cancer (hnc)market covered in this report is segmented –
1) By Type: Laryngeal Cancer, Pharyngeal Cancer, Salivary Gland Cancer, Lip And Oral Cavity Cancer, Nasopharyngeal Cancer, Other Types
2) By Treatment: Chemotherapy, Surgery, Radiation Therapy, Targeted Therapy, Other Treatments
3) By Diagnosis: Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, Endoscopy
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, E-commerce
5) By End User: Hospital, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Laryngeal Cancer: Supraglottic Laryngeal Cancer; Glottic Laryngeal Cancer; Subglottic Laryngeal Cancer
2) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
3) By Salivary Gland Cancer: Parotid Gland Cancer; Sublingual Gland Cancer; Submandibular Gland Cancer; Minor Salivary Gland Cancer
4) By Lip And Oral Cavity Cancer: Lip Cancer; Buccal Mucosa Cancer; Tongue Cancer; Gingival Cancer; Palate Cancer
5) By Nasopharyngeal Cancer: Early-Stage Nasopharyngeal Cancer; Advanced-Stage Nasopharyngeal Cancer
6) By Other Types: Thyroid Cancer; Esophageal Cancer; Sinonasal Cancer
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20825&type=smp
Which Areas Are Leading Regions in the Head And Neck Cancer (HNC) Market Expansion Across the Globe?
North America was the largest region in the head and neck cancer (HNC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer (HNC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theHead And Neck Cancer (HNC) Market Direction?
Key industry players in the head and neck cancer (HNC) market are honing in on the creation and development of groundbreaking products like immune oncology drugs. Their goal is to increase treatment efficiency, boost the survival rates of patients, and meet the medical necessities that have not been satisfactorily addressed in the management of complicated and advanced cancers. Immuno-oncology medicines are those that employ the immunity system of the body to identify and combat cancer cells, including such treatments as checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines. To illustrate, Dr. Reddy’s Laboratories, an Indian pharmaceutical firm, introduced an immune oncology drug, toripalimab, in November 2024. This drug is designed for adults suffering from a unique form of head and neck cancer stemming from the nasopharynx or the upper region of the throat: recurrent or metastatic nasopharyngeal carcinoma. To be sold under the Zytorvi brand name, this drug has shown to lower the risk of progression or death by 48% when paired with the standard chemotherapy treatments, gemcitabine and cisplatin.
View the full report here:
https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-hnc-global-market-report
How Is the Head And Neck Cancer (HNC) Market Conceptually Defined?
Head and neck cancer (HNC) refers to a group of epithelial malignancies arising in the head and neck region, including the oral cavity, pharynx, larynx, nasal cavity, and salivary glands. The majority are squamous cell carcinomas, with risk factors including tobacco, alcohol, and human papillomavirus (HPV) infection.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20825
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model